Waldenström macroglobulinemia: 2011 update on diagnosis, risk stratification, and management
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Waldenström macroglobulinemia: 2011 update on diagnosis, risk stratification, and management
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 86, Issue 5, Pages 411-416
Publisher
Wiley
Online
2011-04-26
DOI
10.1002/ajh.22014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IgM multiple myeloma: Disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia
- (2010) Steven R. Schuster et al. AMERICAN JOURNAL OF HEMATOLOGY
- review: Current status of stem cell mobilization
- (2010) Morie A. Gertz BRITISH JOURNAL OF HAEMATOLOGY
- Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia
- (2010) I. M. Ghobrial et al. CLINICAL CANCER RESEARCH
- Prevalence, clinical aspects, and natural history of IgM MGUS
- (2010) Mary L. McMaster et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Prognostic Factors in Follicular Lymphoma
- (2010) Thomas Relander et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Weekly Bortezomib in Combination With Rituximab in Relapsed or Relapsed and Refractory Waldenström Macroglobulinemia
- (2010) Irene M. Ghobrial et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Relapsed or Refractory Waldenström Macroglobulinemia
- (2010) Irene M. Ghobrial et al. JOURNAL OF CLINICAL ONCOLOGY
- High-Dose Therapy and Autologous Stem-Cell Transplantation in Waldenström Macroglobulinemia: The Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
- (2010) Charalampia Kyriakou et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy
- (2010) D A Carney et al. LEUKEMIA
- Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia
- (2010) Stefan Peinert et al. LEUKEMIA & LYMPHOMA
- Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH)
- (2010) Efstathios Kastritis et al. LEUKEMIA RESEARCH
- Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines
- (2010) Stephen M. Ansell et al. MAYO CLINIC PROCEEDINGS
- Novel treatment regimens for Waldenström’s macroglobulinemia
- (2010) Ramón García-Sanz et al. Expert Review of Hematology
- International prognostic scoring system for Waldenstrom macroglobulinemia
- (2009) P. Morel et al. BLOOD
- How I treat Waldenstrom macroglobulinemia
- (2009) S. P. Treon BLOOD
- Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial
- (2009) Morie A. Gertz et al. BRITISH JOURNAL OF HAEMATOLOGY
- Monoclonal gammopathy and neuropathy
- (2009) Sindhu Ramchandren et al. CURRENT OPINION IN NEUROLOGY
- Primary Therapy of Waldenström Macroglobulinemia With Bortezomib, Dexamethasone, and Rituximab: WMCTG Clinical Trial 05-180
- (2009) Steven P. Treon et al. JOURNAL OF CLINICAL ONCOLOGY
- Beyond R-CHOP and the IPI in large-cell lymphoma: Molecular markers as an opportunity for stratification
- (2009) Jason R. Westin et al. Current Hematologic Malignancy Reports
- Thalidomide and rituximab in Waldenstrom macroglobulinemia
- (2008) S. P. Treon et al. BLOOD
- Lenalidomide and Rituximab in Waldenstrom's Macroglobulinemia
- (2008) S. P. Treon et al. CLINICAL CANCER RESEARCH
- Lymphoplasmacytic lymphoma–Waldenstrom's macroglobulinemia
- (2008) Umberto Vitolo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The International Prognostic Scoring System for Waldenstrom's macroglobulinemia is applicable in patients treated with rituximab-based regimens
- (2008) M. A. Dimopoulos et al. HAEMATOLOGICA
- Increased Incidence of Transformation and Myelodysplasia/Acute Leukemia in Patients With Waldenström Macroglobulinemia Treated With Nucleoside Analogs
- (2008) Xavier Leleu et al. JOURNAL OF CLINICAL ONCOLOGY
- The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)
- (2008) C Buske et al. LEUKEMIA
- Pathogenesis and progression of monoclonal gammopathy of undetermined significance
- (2008) J Bladé et al. LEUKEMIA
- Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemia
- (2008) Xavier Leleu et al. LEUKEMIA & LYMPHOMA
- Neurological manifestations of Waldenström macroglobulinemia
- (2008) Joachim M Baehring et al. Nature clinical practice. Neurology
- The incidence and survival of Waldenström's Macroglobulinaemia in South East England
- (2007) K.J. Phekoo et al. LEUKEMIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started